Atlas Trials

Observational Study on the Effect of Switch to Lurasidone in Subjects With Schizophrenia"

Clinical trial NCT04312503 · COMPLETED

Trial details

NCT number
NCT04312503
Sponsor
Aziende Chimiche Riunite Angelini Francesco S.p.A
Status
COMPLETED
Study type
OBSERVATIONAL
Schizophrenia
Start date
2020-07-13
Primary completion
2022-10-31
Enrollment
95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.